2Kellenberg CG.The diagnosis and classification of microscopic polyangiitis[J].J Autoimmun,2014,48-49:90-93.
3Huang H,Wang YX,Jiang CG,et al.A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China[J].BMC Pulm Med,2014,14:8.
4Guilpain P,Chereau C,Goulvestre C,et al.The oxidation induced by anti-MPO anibodies triggers fibrosis in microscopic Polyangitis[J].Eur Resir J,2011,37:1503.
5Guillevin L,Durand-Gassel B,Cevallos R,et al.Clinical and laboratory findings in eighty-five patients[J].Arthritis Rheum,1999,42:421-430.
6Sugiyama K,Sada KE,Kurosawa M,et al.Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan[J].Clin Exp Nephrol,2013,17:51.
7Lhote F,Cohen P,Guillevin L,et al.Polyarteritis nodosa,microscopic polyangiitis and Churg-strauss Syndrome[J].Lupus,1998,7:238-258.
8Ferrario F,Vanzati A,Pagni F,et al.Pathology of ANCA-associated vasculitis[J].Clin Exp Nephrol,2013,17:652-658.
9Westman KW,Byqren PG,Olsson H,et al.Relapse rate,renal survival,and cancer morbidity in patients with Wegena’s granulomatosis or microscopic polyangiitis with renal involvement[J].J Am Soc Nephrol,1998,9:842-852.
10Levy JB,Hammad T,Coulthart A,et al.Clinical features and outcome of patients with both ANCA and anti-GBM antibodies[J].Kidney Int,2004,66:1535-1540.
